Compare Eli Lilly And Co (LLY) vs Lockheed Martin Corporation (LMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Lockheed Martin Corporation — how do they compare? Eli Lilly And Co trades at $1,174.1 (market cap $1.02T), while Lockheed Martin Corporation trades at $507.08 (market cap $117.48B). The key difference: Eli Lilly And Co is far larger — about 8.7× Lockheed Martin Corporation's market cap, and Lockheed Martin Corporation pays the higher dividend (2.71%). Which is the better fit depends on your goals.
| LLY | LMT | |
|---|---|---|
Market Cap | $1.02T | $117.48B |
Sector | Health | Industrials |
52-Week High | $1.24K | $676.70 |
52-Week Low | $625.65 | $410.74 |
Enterprise Value | $1.06T | $136.28B |
Dividend Yield | 0.6% | 2.71% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Lockheed Martin Corporation
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →
